Načítá se...
CD28z CARs and Armored CARs
CD19-targeted chimeric antigen receptor (CAR) T cells are currently being tested in the clinic with very promising outcomes. However, limitations to CAR T cell therapy exist. These include lack of efficacy against some tumors, specific targeting of tumor cells without affecting normal tissue and ret...
Uloženo v:
| Vydáno v: | Cancer J |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687893/ https://ncbi.nlm.nih.gov/pubmed/24667958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000034 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|